A Yale research team has found that by tinkering with the surface properties of drug-loaded nanoparticles, they can potentially direct these particles to specific cells in the brain. (more…)
Brain cancer researcher travels to Oslo for dissertation defense
As winter weather hit Newark, Del., on Sunday, Dec. 8, a University of Delaware brain cancer researcher escaped the storm by traveling to Oslo, Norway, of all places.
The Norwegian capital also received its first snow of the season that day, but it only accumulated to about three inches, according to Deni Galileo, associate professor of biological sciences at UD. He traveled to Oslo to take part in the Ph.D. defense of Mrinal Joel, a University of Oslo doctoral student who, like Galileo, is working on the most lethal type of brain cancer, Glioblastoma multiforme. (more…)
Dr. Alfredo Quiñones-Hinojosa may not be able to cure his patients’ brain cancer, but there is one thing that the internationally renowned neurosurgeon and neuroscientist can provide them with: hope.
During a recent visit to campus Quiñones-Hinojosa discussed his journey from a migrant farm worker to a doctor who researches the deadliest form of brain cancer, glioblastomas. His talk was sponsored by La Casa Cultural Center, the Latino Cultural Center at Yale. (more…)
The U is at the forefront of cancer research in dogs
After more than an hour discussing the shared evolution of dogs and humans, and how the cancer mysteries that lie deep within one may inform and effect treatments on the other, U researcher Jaime Modiano smiles and says, “I love my job.”
And why not?
He’s at the forefront of an array of exciting research that stands to improve the health of both dogs and people. (more…)
Researchers with UCLA’s Jonsson Comprehensive Cancer Center have developed a new screening approach to identify chemical compounds that can target and kill the stem cells responsible for creating deadly brain tumors.
Glioblastoma is one of the deadliest malignancies, typically killing patients within 12 to 18 months. These brain cancers consist of two kinds of cells: a larger, heterogeneous population of tumor cells and a smaller sub-population of stem cells, which are treatment-resistant. (more…)
